Stock Analysis
- France
- /
- Diversified Financial
- /
- ENXTPA:RF
Top Growth Companies With High Insider Ownership On Euronext Paris
Reviewed by Simply Wall St
The French stock market, represented by the CAC 40 Index, has shown resilience amid global volatility, gaining 0.25% in recent trading sessions. As investors navigate through mixed economic signals and fluctuating consumer demand, identifying growth companies with high insider ownership can offer a measure of confidence and alignment with shareholder interests.
Top 10 Growth Companies With High Insider Ownership In France
Name | Insider Ownership | Earnings Growth |
Groupe OKwind Société anonyme (ENXTPA:ALOKW) | 24.8% | 36% |
VusionGroup (ENXTPA:VU) | 13.4% | 25.7% |
Adocia (ENXTPA:ADOC) | 11.9% | 63% |
Icape Holding (ENXTPA:ALICA) | 30.2% | 35.1% |
Arcure (ENXTPA:ALCUR) | 21.4% | 27.5% |
La Française de l'Energie (ENXTPA:FDE) | 19.9% | 31.9% |
S.M.A.I.O (ENXTPA:ALSMA) | 17.3% | 35.2% |
Munic (ENXTPA:ALMUN) | 29.4% | 149.2% |
OSE Immunotherapeutics (ENXTPA:OSE) | 25.6% | 5.9% |
MedinCell (ENXTPA:MEDCL) | 15.8% | 71.1% |
Let's take a closer look at a couple of our picks from the screened companies.
MedinCell (ENXTPA:MEDCL)
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A. is a pharmaceutical company based in France that develops long-acting injectables across various therapeutic areas, with a market cap of €501.47 million.
Operations: MedinCell generates €11.95 million in revenue from its pharmaceuticals segment.
Insider Ownership: 15.8%
Earnings Growth Forecast: 71.1% p.a.
MedinCell's revenue is forecast to grow at 44.7% per year, significantly outpacing the French market's 5.8% growth rate, with earnings expected to increase by 71.06% annually. The company is trading at a substantial discount of 87.4% below its estimated fair value and aims to become profitable within three years, surpassing average market growth rates. Recent earnings showed a slight decline in sales and revenue but an improved net loss of €25.04 million from €32.01 million last year.
- Click to explore a detailed breakdown of our findings in MedinCell's earnings growth report.
- Upon reviewing our latest valuation report, MedinCell's share price might be too optimistic.
OVH Groupe (ENXTPA:OVH)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: OVH Groupe S.A. offers public and private cloud services, shared hosting, and dedicated server solutions globally, with a market cap of approximately €1.15 billion.
Operations: The company's revenue segments include Public Cloud (€169.01 million), Private Cloud (€589.61 million), and Web Cloud (€185.43 million).
Insider Ownership: 10.5%
Earnings Growth Forecast: 101.1% p.a.
OVH Groupe is forecast to grow earnings by 101.12% annually and become profitable within three years, outpacing average market growth. The company trades at 31.9% below its estimated fair value. Recent innovations include the launch of ADV-Gen3 Bare Metal servers powered by AMD EPYC 4004 processors, enhancing performance and price ratio for diverse use cases like web hosting and virtualization, with improved network redundancy ensuring business continuity.
- Unlock comprehensive insights into our analysis of OVH Groupe stock in this growth report.
- Our valuation report unveils the possibility OVH Groupe's shares may be trading at a discount.
Eurazeo (ENXTPA:RF)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Eurazeo SE is a private equity and venture capital firm focusing on growth capital, acquisitions, leveraged buyouts, and investments in mid-market and listed public companies with a market cap of €5.03 billion.
Operations: Eurazeo SE's revenue segments include growth capital, acquisitions, leveraged buyouts, and investments in mid-market and listed public companies.
Insider Ownership: 12.1%
Earnings Growth Forecast: 37.6% p.a.
Eurazeo SE, a growth company with high insider ownership in France, reported H1 2024 earnings of €180.71 million, up from €171.18 million last year, but faced a net loss of €104.56 million. Despite this setback, the firm’s revenue is expected to grow at 45.2% annually and become profitable within three years. The stock trades at 83% below its estimated fair value and analysts predict a price increase of 35%.
- Get an in-depth perspective on Eurazeo's performance by reading our analyst estimates report here.
- The analysis detailed in our Eurazeo valuation report hints at an deflated share price compared to its estimated value.
Seize The Opportunity
- Unlock our comprehensive list of 23 Fast Growing Euronext Paris Companies With High Insider Ownership by clicking here.
- Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
- Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Eurazeo might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:RF
Eurazeo
A private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies.